KOCAA
Knights of Columbus Asset Advisors Portfolio holdings
AUM
$1.65B
1-Year Return
26.62%
This Quarter Return
+9.41%
1 Year Return
+26.62%
3 Year Return
+114.99%
5 Year Return
+224.68%
10 Year Return
–
AUM
$1.02B
AUM Growth
+$51.2M
(+5.3%)
Cap. Flow
-$7.76M
Cap. Flow
% of AUM
-0.76%
Top 10 Holdings %
Top 10 Hldgs %
22.01%
Holding
381
New
37
Increased
219
Reduced
64
Closed
20
Top Buys
| 1 |
Mondelez International
MDLZ
|
$6.39M |
| 2 |
Boston Scientific
BSX
|
$4.51M |
| 3 |
Cencora
COR
|
$4.5M |
| 4 |
American International
AIG
|
$4.23M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$3.94M |
Top Sells
| 1 |
Eli Lilly
LLY
|
$13.5M |
| 2 |
Amgen
AMGN
|
$12.8M |
| 3 |
Bristol-Myers Squibb
BMY
|
$11.7M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
$3.96M |
| 5 |
Jazz Pharmaceuticals
JAZZ
|
$3.04M |
Sector Composition
| 1 | Technology | 21.12% |
| 2 | Financials | 14.71% |
| 3 | Industrials | 11.11% |
| 4 | Consumer Discretionary | 11.04% |
| 5 | Healthcare | 10.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
251
Idexx Laboratories
IDXX
$51.8B
| $704K | 0.07% |
+1,408
| New | +$704K |
|
252
Oracle
ORCL
$648B
| $691K | 0.07% |
7,438
+146
| +2% | +$13.6K |
|
253
TechTarget
TTGT
$401M
| $689K | 0.07% |
19,087
-15,289
| -44% | -$552K |
|
254
Amazon
AMZN
$2.48T
| $641K | 0.06% |
6,202
-2,601
| -30% | -$269K |
|
255
Marathon Petroleum
MPC
$54.2B
| $629K | 0.06% |
4,665
+966
| +26% | +$130K |
|
|
256
Eli Lilly
LLY
$653B
| $622K | 0.06% |
1,812
-39,380
| -96% | -$13.5M |
|
257
Ingevity
NGVT
$2.17B
| $622K | 0.06% |
+8,690
| New | +$622K |
|
258
Walt Disney
DIS
$212B
| $599K | 0.06% |
5,982
+1,519
| +34% | +$152K |
|
259
VICI Properties
VICI
$35.7B
| $593K | 0.06% |
+18,167
| New | +$593K |
|
260
Castle Biosciences
CSTL
$686M
| $586K | 0.06% |
25,813
+22
| +0.1% | +$500 |
|
261
Magnite
MGNI
$3.51B
| $585K | 0.06% |
63,165
| – | – |
|
262
Verizon
VZ
$186B
| $584K | 0.06% |
15,023
-246
| -2% | -$9.57K |
|
263
Deckers Outdoor
DECK
$17.9B
| $556K | 0.05% |
7,422
+78
| +1% | +$5.84K |
|
264
Thermo Fisher Scientific
TMO
$185B
| $554K | 0.05% |
962
-11
| -1% | -$6.34K |
|
265
Bally's
BALY
$477M
| $550K | 0.05% |
28,191
-22,167
| -44% | -$433K |
|
266
Merck
MRK
$211B
| $528K | 0.05% |
4,965
-980
| -16% | -$104K |
|
267
Revolve Group
RVLV
$1.68B
| $523K | 0.05% |
19,879
| – | – |
|
268
Campbell Soup
CPB
$10.1B
| $519K | 0.05% |
9,437
+3,891
| +70% | +$214K |
|
|
269
Amgen
AMGN
$152B
| $515K | 0.05% |
2,131
-53,048
| -96% | -$12.8M |
|
270
Accuray
ARAY
$169M
| $507K | 0.05% |
170,661
| – | – |
|
271
Match Group
MTCH
$9.06B
| $494K | 0.05% |
12,857
| – | – |
|
272
ASML
ASML
$306B
| $462K | 0.05% |
679
+207
| +44% | +$141K |
|
273
Johnson & Johnson
JNJ
$426B
| $443K | 0.04% |
2,858
+84
| +3% | +$13K |
|
274
Nucor
NUE
$33.6B
| $418K | 0.04% |
2,709
-40
| -1% | -$6.18K |
|
|
ACCD
275
DELISTED
Accolade, Inc. Common Stock
ACCD
| $389K | 0.04% |
27,062
| – | – |
|